Haoxi Health Technology Limited
HAO
$0.98
-$0.03-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -64.63% | -64.63% | 1.92% | 1.92% | 31.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -64.63% | -64.63% | 1.92% | 1.92% | 31.20% |
| Cost of Revenue | -64.20% | -64.20% | 5.25% | 5.25% | 32.32% |
| Gross Profit | -71.12% | -71.12% | -60.01% | -60.01% | 16.31% |
| SG&A Expenses | 284.03% | 284.03% | 53.38% | 53.38% | 1.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -55.54% | -55.54% | 6.16% | 6.16% | 31.33% |
| Operating Income | -308.34% | -308.34% | -115.57% | -115.57% | 27.85% |
| Income Before Tax | 343.36% | 343.36% | -99.75% | -99.75% | 32.74% |
| Income Tax Expenses | -91.03% | -91.03% | 486.50% | 486.50% | 122.25% |
| Earnings from Continuing Operations | 673.28% | 673.28% | -130.60% | -130.60% | 1.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 673.28% | 673.28% | -130.60% | -130.60% | 1.64% |
| EBIT | -308.34% | -308.34% | -115.57% | -115.57% | 27.85% |
| EBITDA | -275.56% | -275.17% | -114.19% | -114.19% | 27.39% |
| EPS Basic | 243.84% | 243.84% | -119.89% | -119.89% | -4.34% |
| Normalized Basic EPS | 97.13% | 97.13% | -99.81% | -99.81% | 24.96% |
| EPS Diluted | 172.68% | 172.68% | -119.89% | -119.89% | 0.96% |
| Normalized Diluted EPS | 88.80% | 88.80% | -99.81% | -99.81% | 24.96% |
| Average Basic Shares Outstanding | 124.90% | 124.90% | 53.90% | 53.90% | 6.26% |
| Average Diluted Shares Outstanding | 134.81% | 134.81% | 53.90% | 53.90% | 6.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |